<div id=toc></div>

# Table of Contents

- [q-bio.QM](#q-bio.QM) [Total: 5]
- [q-bio.MN](#q-bio.MN) [Total: 2]
- [stat.AP](#stat.AP) [Total: 1]
- [cs.LG](#cs.LG) [Total: 1]


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [1] [Project Hermes: A Model-Agnostic Validation Layer for Wearable Health Prediction Systems](https://arxiv.org/abs/2602.18643)
*Richik Chakraborty*

Main category: q-bio.QM

TL;DR: Project Hermes是一个模型无关的验证层，使用LLM生成上下文查询来获取用户反馈，通过贝叶斯置信度更新来验证可穿戴设备健康预测信号的真伪，减少误报率。


<details>
  <summary>Details</summary>
Motivation: 可穿戴健康预测系统在不确定性下生成警报，但缺乏针对用户的验证机制。现有LLM在医疗领域的应用主要集中在诊断生成和风险预测，而非预测后信号的验证。

Method: 将信号确认视为顺序决策问题，在上游预测器下游运行，使用LLM生成上下文查询获取用户针对性反馈，通过贝叶斯置信度更新区分真阳性和误报。

Result: 在60天偏头痛预测纵向案例研究中，误报率降低34%（从61.7%降至12.5%），同时保持89%的灵敏度，症状发作前平均提前时间为4.2小时。

Conclusion: 验证应被视为与预测不同的独立计算问题，这项工作为消费者健康AI系统的可信部署奠定了基础，Hermes不进行诊断或新预测，只验证上游模型检测的信号是否对特定个体在特定时间具有临床意义。

Abstract: The deployment of wearable-based health prediction systems has accelerated rapidly, yet these systems face a fundamental challenge: they generate alerts under substantial uncertainty without principled mechanisms for user-specific validation. While large language models (LLMs) have been increasingly applied to healthcare tasks, existing work focuses predominantly on diagnosis generation and risk prediction rather than post-prediction validation of detected signals. We introduce Project Hermes, a model-agnostic validation layer that treats signal confirmation as a sequential decision problem. Hermes operates downstream of arbitrary upstream predictors, using LLM-generated contextual queries to elicit targeted user feedback and performing Bayesian confidence updates to distinguish true positives from false alarms. In a 60-day longitudinal case study of migraine prediction, Hermes achieved a 34% reduction in false positive rate (from 61.7% to 12.5%) while maintaining 89% sensitivity, with mean lead time of 4.2 hours before symptom onset. Critically, Hermes does not perform diagnosis or make novel predictions; it validates whether signals detected by upstream models are clinically meaningful for specific individuals at specific times. This work establishes validation as a first-class computational problem distinct from prediction, with implications for trustworthy deployment of consumer health AI systems.

</details>


### [2] [AAVGen: Precision Engineering of Adeno-associated Viral Capsids for Renal Selective Targeting](https://arxiv.org/abs/2602.18915)
*Mohammadreza Ghaffarzadeh-Esfahani,Yousof Gheisari*

Main category: q-bio.QM

TL;DR: AAVGen是一个生成式AI框架，用于从头设计具有增强多特性谱的AAV衣壳，通过整合蛋白质语言模型、监督微调和强化学习，优化生产适应性、肾脏趋向性和热稳定性。


<details>
  <summary>Details</summary>
Motivation: 天然AAV血清型在组织趋向性、免疫逃逸和生产效率方面存在局限，而肾脏等器官具有独特的解剖屏障和细胞靶点，需要精确的载体工程。传统方法难以同时优化多个功能特性，且序列空间巨大。

Method: AAVGen整合了蛋白质语言模型（PLM）与监督微调（SFT）以及强化学习技术Group Sequence Policy Optimization（GSPO）。模型由三个ESM-2回归预测器组成的复合奖励信号指导，分别预测生产适应性、肾脏趋向性和热稳定性。

Result: AAVGen生成了多样化的新型VP1蛋白序列库。计算机验证显示大多数生成变体在所有三个指标上均表现出优越性能，实现了成功的多目标优化。AlphaFold3结构分析确认生成序列在序列多样化的同时保持了规范的衣壳折叠。

Conclusion: AAVGen为数据驱动的病毒载体工程奠定了基础，加速了具有定制功能特性的下一代AAV载体的开发。

Abstract: Adeno-associated viruses (AAVs) are promising vectors for gene therapy, but their native serotypes face limitations in tissue tropism, immune evasion, and production efficiency. Engineering capsids to overcome these hurdles is challenging due to the vast sequence space and the difficulty of simultaneously optimizing multiple functional properties. The complexity also adds when it comes to the kidney, which presents unique anatomical barriers and cellular targets that require precise and efficient vector engineering. Here, we present AAVGen, a generative artificial intelligence framework for de novo design of AAV capsids with enhanced multi-trait profiles. AAVGen integrates a protein language model (PLM) with supervised fine-tuning (SFT) and a reinforcement learning technique termed Group Sequence Policy Optimization (GSPO). The model is guided by a composite reward signal derived from three ESM-2-based regression predictors, each trained to predict a key property: production fitness, kidney tropism, and thermostability. Our results demonstrate that AAVGen produces a diverse library of novel VP1 protein sequences. In silico validations revealed that the majority of the generated variants have superior performance across all three employed indices, indicating successful multi-objective optimization. Furthermore, structural analysis via AlphaFold3 confirms that the generated sequences preserve the canonical capsid folding despite sequence diversification. AAVGen establishes a foundation for data-driven viral vector engineering, accelerating the development of next-generation AAV vectors with tailored functional characteristics.

</details>


### [3] [An Interpretable Data-Driven Model of the Flight Dynamics of Hawks](https://arxiv.org/abs/2602.19196)
*Lydia France,Karl Lapo,J. Nathan Kutz*

Main category: q-bio.QM

TL;DR: 研究人员使用动态模态分解(DMD)分析鹰的飞行数据，发现复杂飞行行为可由简单模态结构线性组合而成，仅需3-4个参数即可准确重建飞行动力学。


<details>
  <summary>Details</summary>
Motivation: 尽管鸟类飞行已有大量分析，但缺乏基于真实数据的生成物理模型。理解敏捷飞行的底层机制很重要，但飞行涉及多个目标，使整体机制分析复杂化。

Method: 使用数据驱动的动态模态分解(DMD)方法，分析鹰的运动捕捉记录，识别飞行行为的模态结构。

Result: 发现多种飞行状态（振翅、转向、着陆、滑翔）可由简单可解释的模态结构线性组合重现；仅需3个参数描述振翅，第4个参数整合转向；不同鹰个体共享相同的动态模态集。

Conclusion: DMD方法可直接拟合真实数据，比传统物理模型更准确；飞行机制显示主导模态间的参数耦合，类似于最简单行走模型，表明运动效率的优化。

Abstract: Despite significant analysis of bird flight, generative physics models for flight dynamics do not currently exist. Yet the underlying mechanisms responsible for various flight manoeuvres are important for understanding how agile flight can be accomplished. Even in a simple flight, multiple objectives are at play, complicating analysis of the overall flight mechanism. Using the data-driven method of dynamic mode decomposition (DMD) on motion capture recordings of hawks, we show that multiple behavioral states such as flapping, turning, landing, and gliding, can be modeled by simple and interpretable modal structures (i.e. the underlying wing-tail shape) which can be linearly combined to reproduce the experimental flight observations. Moreover, the DMD model can be used to extrapolate naturalistic flapping. Flight is highly individual, with differences in style across the hawks, but we find they share a common set of dynamic modes. The DMD model is a direct fit to data, unlike traditional models constructed from physics principles which can rarely be tested on real data and whose assumptions are typically invalid in real flight. The DMD approach gives a highly accurate reconstruction of the flight dynamics with only three parameters needed to characterize flapping, and a fourth to integrate turning manoeuvres. The DMD analysis further shows that the underlying mechanism of flight, much like simplest walking models, displays a parametric coupling between dominant modes suggesting efficiency for locomotion.

</details>


### [4] [Time-Varying Hazard Patterns and Co-Mutation Profiles of KRAS G12C and G12D in Real-World NSCLC](https://arxiv.org/abs/2602.19295)
*Robert Amevor,Dennis Baidoo,Emmanuel Kubuafor*

Main category: q-bio.QM

TL;DR: KRAS G12D突变在NSCLC中表现出早期治疗时间优势，总生存期优于G12C，支持针对G12D的等位基因特异性治疗开发。


<details>
  <summary>Details</summary>
Motivation: KRAS突变是NSCLC中最常见的致癌突变，虽然G12C已有靶向治疗，但G12D尚无获批疗法。研究旨在比较G12C和G12D在真实世界中的临床结局差异。

Method: 使用AACR Project GENIE BPC NSCLC v2.0-public数据，分析162例TTNT可评估患者。采用Kaplan-Meier、多变量Cox回归和预设的分段Cox模型（以中位TTNT=23个月为界），评估时间变化效应。使用Schoenfeld残差检验比例风险假设，Bootstrap重采样验证稳定性。

Result: G12D在早期TTNT阶段显示优势（HR=0.41，p=0.043），总生存期也优于G12C（HR=0.63，p=0.048）。G12C肿瘤具有更高的TMB和STK11/KEAP1富集。晚期TTNT差异不显著。

Conclusion: KRAS G12D在早期治疗反应和总生存期方面优于G12C，支持针对G12D等位基因特异性治疗的开发，但需要在更大队列中验证。

Abstract: Background: KRAS mutations are the largest oncogenic subset in NSCLC. While KRAS G12C is now targetable, no approved therapies exist for G12D. We examined time-to-next-treatment (TTNT) and overall survival (OS) differences between G12C and G12D, allowing for time-varying hazard effects. Methods: De-identified data from AACR Project GENIE BPC NSCLC v2.0-public were analyzed. TTNT served as a real-world surrogate for progression-free survival. Co-mutations (TP53, STK11, KEAP1, SMARCA4, MET), TMB, and PD-L1 were harmonized. Kaplan-Meier, multivariable Cox, and a pre-specified piecewise Cox model (split at median TTNT = 23 months) were applied. Schoenfeld residuals assessed proportional hazards; bootstrap resampling (B=1000) evaluated stability. Results: Among 162 TTNT-evaluable patients (G12C n=130; G12D n=32), median TTNT was 28.6 versus 32.0 months (log-rank p=0.79). Adjusted Cox regression showed no overall hazard difference (HR=0.85; 95% CI 0.53-1.37; p=0.50), but Schoenfeld testing indicated borderline non-proportionality (p=0.053). Piecewise Cox modeling revealed time-varying effects: early TTNT hazard favored G12D (HR=0.41; 95% CI 0.17-0.97; p=0.043) with significant KRAS x period interaction (HR=3.33; p=0.021) and late-period attenuation (HR=1.38; 95% CI 0.77-2.47; p=0.285). Bootstrap resampling confirmed this pattern (median HRearly=0.39; HRlate=1.41). Among 278 OS-evaluable patients (133 deaths), G12D showed improved OS (adjusted HR=0.63; 95% CI 0.39-0.99; p=0.048). G12C tumors exhibited higher TMB (9.79 vs 7.83 mut/Mb; p=0.002) and greater STK11/KEAP1 enrichment. Conclusions: KRAS G12D demonstrated early TTNT advantage and improved OS. Late-period TTNT differences were non-significant (post-hoc power: 12.3%). These exploratory findings require validation in larger cohorts but support allele-specific therapeutic development for G12D.

</details>


### [5] [Exact Discrete Stochastic Simulation with Deep-Learning-Scale Gradient Optimization](https://arxiv.org/abs/2602.19775)
*Jose M. G. Vilar,Leonor Saiz*

Main category: q-bio.QM

TL;DR: 提出一种解耦前向模拟与反向微分的连续时间马尔可夫链精确随机模拟方法，通过Gumbel-Softmax直通代理实现梯度传播，支持大规模参数优化。


<details>
  <summary>Details</summary>
Motivation: 传统Gillespie算法中的硬分类事件选择阻碍了基于梯度的学习，限制了在系统生物学、化学动力学等领域进行高维参数推断和逆向设计的能力。

Method: 将前向模拟与反向微分解耦：使用硬分类采样生成精确轨迹，通过连续的大规模并行Gumbel-Softmax直通代理传播梯度，实现自动微分兼容。

Result: 在可逆二聚化模型（0.09%误差）、遗传振荡器（1.2%误差）、203,796参数基因调控网络（98.4% MNIST准确率）和离子通道门控实验数据（R^2=0.987）上验证了准确性、可扩展性和可靠性。GPU实现达到每秒19亿步，与非可微分模拟器规模相当。

Conclusion: 该方法使精确随机模拟实现大规模并行且兼容自动微分，为系统生物学、化学动力学、物理学等连续时间马尔可夫链控制领域的高维参数推断和逆向设计开辟了新途径。

Abstract: Exact stochastic simulation of continuous-time Markov chains (CTMCs) is essential when discreteness and noise drive system behavior, but the hard categorical event selection in Gillespie-type algorithms blocks gradient-based learning. We eliminate this constraint by decoupling forward simulation from backward differentiation, with hard categorical sampling generating exact trajectories and gradients propagating through a continuous massively-parallel Gumbel-Softmax straight-through surrogate. Our approach enables accurate optimization at parameter scales over four orders of magnitude beyond existing simulators. We validate for accuracy, scalability, and reliability on a reversible dimerization model (0.09% error), a genetic oscillator (1.2% error), a 203,796-parameter gene regulatory network achieving 98.4% MNIST accuracy (a prototypical deep-learning multilayer perceptron benchmark), and experimental patch-clamp recordings of ion channel gating (R^2 = 0.987) in the single-channel regime. Our GPU implementation delivers 1.9 billion steps per second, matching the scale of non-differentiable simulators. By making exact stochastic simulation massively parallel and autodiff-compatible, our results enable high-dimensional parameter inference and inverse design across systems biology, chemical kinetics, physics, and related CTMC-governed domains.

</details>


<div id='q-bio.MN'></div>

# q-bio.MN [[Back]](#toc)

### [6] [Modeling Dynamics, Cell Type Specificity, and Perturbations in Gene Regulatory Networks](https://arxiv.org/abs/2602.18854)
*Junha Shin,Spencer Halberg-Spencer,Yuda Liu,Suvojit Hazra,Erika Da-Inn Lee,Sushmita Roy*

Main category: q-bio.MN

TL;DR: 这篇综述总结了从单细胞组学数据推断基因调控网络（GRN）的现状，重点关注动态和扰动分析，并指出了该领域的关键开放挑战。


<details>
  <summary>Details</summary>
Motivation: 基因调控网络（GRN）在发育、疾病和进化等生物过程中起关键作用，但全面表征这些网络在不同细胞类型和状态中仍然是一个重大挑战。单细胞组学技术的进步为计算推断GRN提供了新的机会。

Method: 这是一篇综述论文，总结了当前从单细胞组学数据推断GRN的计算方法，特别关注动态调控过程和扰动分析。

Result: 综述了单细胞组学技术如何增强GRN推断能力，提供了对细胞类型特异性机制、因果关系和动态调控过程的深入理解。

Conclusion: 该领域需要解决关键开放挑战才能进一步发展，包括改进GRN推断方法以更好地捕捉动态和扰动效应。

Abstract: Gene regulatory networks (GRNs) define the regulatory relationships among molecules such as transcription factors, chromatin remodelers, and target genes. GRNs play a critical role in diverse biological processes, including development, disease manifestation, and evolution. However, fully characterizing these networks across multiple cell types and states remains a significant challenge. Recent advances in single-cell omics have dramatically enhanced our ability to measure biological systems at unprecedented resolution. These technologies have opened new avenues for computational methods to infer GRNs, offering deeper insights into cell type-specific mechanisms, causality, and dynamic regulatory processes. This review summarizes the current state of GRN inference from single cell omic datasets, with a particular focus on dynamics and perturbations, and outlines key open challenges that must be addressed to advance the field.

</details>


### [7] [Convex Analysis of Relaxation Dynamics in Chemical Reaction Networks and Generalized Gradient Flows](https://arxiv.org/abs/2602.18932)
*Keisuke Sugie,Dimitri Loutchko,Tetsuya J. Kobayashi*

Main category: q-bio.MN

TL;DR: 该论文提出了质量作用化学反应网络（CRNs）中Kullback-Leibler散度到平衡态的界，并扩展了广义梯度流框架，应用于具有平台行为的生物系统。


<details>
  <summary>Details</summary>
Motivation: 化学反应网络在生物学中广泛存在，特别是在准稳态区域中，长时间瞬态和平台行为很常见且功能重要。需要量化这些系统中向平衡态的松弛过程。

Method: 通过奇异值、凸性参数和时间积分活动度，使用变形指数型函数表征衰减率。在广义梯度流框架内扩展这些界，应用于具有准稳态的催化CRN。

Result: 获得了CRNs中Kullback-Leibler散度到平衡态的界，这些界能够捕捉局部凸性引起的缓慢松弛，并为量化CRNs中的松弛提供了基于界的方法。

Conclusion: 该框架适用于具有平台行为的生物相关系统，能够量化准稳态区域中的松弛过程，为理解生物化学网络的动力学提供了理论工具。

Abstract: We obtain bounds on the Kullback--Leibler divergence to equilibrium for mass-action chemical reaction networks (CRNs) with equilibrium. The associated decay rates are characterized in terms of the singular values of the stoichiometric matrix, convexity parameters, and time-integrated activities via deformed-exponential-type functions. We further extend these bounds within a generalized gradient flow framework. We highlight the biological relevance of this framework: the resulting bounds apply to quasi-steady-state regimes, where long transients and plateau-like behavior are common and functionally important. We illustrate the framework using a catalytic CRN exhibiting plateaus, where the bounds capture slow relaxation induced by local convexity and provide a bound-based approach to quantifying relaxation in CRNs.

</details>


<div id='stat.AP'></div>

# stat.AP [[Back]](#toc)

### [8] [Statistical methods for reference-free single-molecule localisation microscopy](https://arxiv.org/abs/2602.18727)
*Jack Peyton,Benjamin Davis,Emily Gribbin,Daniel Rolfe,Hannah Mitchell*

Main category: stat.AP

TL;DR: 提出一个基于贝叶斯和空间统计的端到端分析框架，用于处理MINFLUX单分子成像数据，实现无模板的分子结构重建


<details>
  <summary>Details</summary>
Motivation: MINFLUX成像技术产生的点模式数据存在多种挑战：发射体密度可变、生物标记不完整、测量误差、虚假检测等，使得结构推断困难，现有方法需要主观参数调整和已知结构模板

Method: 开发基于贝叶斯和空间统计方法的端到端分析流程，包括：1）不确定性感知的发射体聚类，2）快速识别分子结构超群，3）无需先验知识的重复结构重建

Result: 在模拟和真实MINFLUX数据集上验证，发射体聚类和中心检测在所有条件下保持高性能（准确率>0.75），结构推断在高标记效率下达到可靠区分（F1约0.9），成功重建Nup96和DNA-Origami 3x3网格结构

Conclusion: 该统计框架为MINFLUX数据分析提供了客观、无模板的方法，克服了现有方法的局限性，实现了高精度的分子结构重建

Abstract: MINFLUX (Minimal Photon Flux) is a single-molecule imaging technique capable of resolving fluorophores at a precision of <5 nm. Interpretation of the point patterns generated by this technique presents challenges due to variable emitter density, incomplete bio-labelling of target molecules and their detection, error prone measurement processes, and the presence of spurious (non-structure associated) fluorescent detections. Together, these challenges ensure structural inferences from single-molecule imaging datasets are non-trivial in the absence of strong a priori information, for all but the smallest of point patterns. In addition, current methods often require subjective parameter tuning and presuppose known structural templates, limiting reference-free discovery. We present a statistically grounded, end-to-end analysis framework. Focusing on MINFLUX derived datasets and leveraging Bayesian and spatial statistical methods, a pipeline is presented that demonstrates 1) uncertainty aware clustering of measurements into emitter groups that performs better than current gold standards, 2) rapid identification of molecular structure supergroups, and 3) reconstruction of repeating structures within the dataset without substantial prior knowledge. This pipeline is demonstrated using simulated and real MINFLUX datasets, where emitter clustering and centre detection maintain high performance (emitter subset assignment accuracy > 0.75) across all conditions evaluated, while structural inference achieves reliable discrimination (F1 approx. 0.9) at high labelling efficiency. Template-free reconstruction of Nup96 and DNA-Origami 3x3 grids are achieved.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [9] [Physiologically Informed Deep Learning: A Multi-Scale Framework for Next-Generation PBPK Modeling](https://arxiv.org/abs/2602.18472)
*Shunqi Liu,Han Qiu,Tong Wang*

Main category: cs.LG

TL;DR: 该论文提出一个统一的科学机器学习框架，结合PBPK模型的机制严谨性和数据驱动的灵活性，通过三个创新方法解决传统PBPK建模的计算成本高、参数识别困难和种间外推不确定性等问题。


<details>
  <summary>Details</summary>
Motivation: 尽管基于生理的药代动力学（PBPK）建模是模型引导药物开发（MIDD）的基石，但其广泛应用受到高计算成本、复杂生物系统参数识别困难以及种间外推不确定性的限制。

Method: 提出统一的科学机器学习（SciML）框架，包含三个核心贡献：1）基础PBPK变换器，将药代动力学预测视为序列建模任务；2）生理约束扩散模型，使用物理信息损失生成符合生物学的虚拟患者群体；3）神经异速生长，结合图神经网络和神经常微分方程学习连续跨物种缩放规律。

Result: 在合成数据集上的实验表明，该框架在约束条件下将生理违规率从2.00%降低到0.50%，同时提供了更快速模拟的途径。

Conclusion: 该SciML框架成功地将机制严谨性与数据驱动灵活性相结合，为PBPK建模提供了更高效、更准确的解决方案，有望促进模型引导药物开发的广泛应用。

Abstract: Physiologically Based Pharmacokinetic (PBPK) modeling is a cornerstone of model-informed drug development (MIDD), providing a mechanistic framework to predict drug absorption, distribution, metabolism, and excretion (ADME). Despite its utility, adoption is hindered by high computational costs for large-scale simulations, difficulty in parameter identification for complex biological systems, and uncertainty in interspecies extrapolation. In this work, we propose a unified Scientific Machine Learning (SciML) framework that bridges mechanistic rigor and data-driven flexibility. We introduce three contributions: (1) Foundation PBPK Transformers, which treat pharmacokinetic forecasting as a sequence modeling task; (2) Physiologically Constrained Diffusion Models (PCDM), a generative approach that uses a physics-informed loss to synthesize biologically compliant virtual patient populations; and (3) Neural Allometry, a hybrid architecture combining Graph Neural Networks (GNNs) with Neural ODEs to learn continuous cross-species scaling laws. Experiments on synthetic datasets show that the framework reduces physiological violation rates from 2.00% to 0.50% under constraints while offering a path to faster simulation.

</details>
